Skip to Content
Cancer Diagnosis Program (CDP) — Biorepositories & Biospecimen Research Branch (BBRB) Cancer Diagnosis Program (CDP) Biorepositories & Biospecimen Research Branch (BBRB)
Contact NExT
Show menu
Search this site
Last Updated: 07/17/17

Mission and Goals

The National Cancer Institute (NCI), through its Biorepositories and Biospecimen Research Branch (BBRB), is leading a national initiative to improve our understanding of cancer by increasing availability and access to quality biospecimens and related clinical data. Through its various initiatives and programs, BBRB facilitates cancer and biomedical research through a strong foundation of networks, tools and resources that supports, guides and informs biospecimen collection and biobanking. Our efforts aim to raise the quality of cancer research and to support the development of better cancer diagnostic tests and treatments.

Five core areas of activity drive our work:

  • Lead the development and continuous improvement of policy for collection and management of biospecimen resources
  • Develop and support scientific research and programs that inform best practices for biospecimen collection, handling and processing
  • Develop educational materials and forums for communication around biospecimen related issues
  • Forge partnerships nationally and internationally to coordinate and communicate biospecimen and biobanking standards as well as facilitate access to biospecimens
  • Provide a resource for direct support of NCI and NIH programs and initiatives that involve biospecimen use and collection and biospecimen research
Image of the BBRB images and goals